Evidence map›Paper›PMID 35108126›Full record

ArticleJournal of telemedicine and telecare2024

Changes in telemedicine use and ambulatory visit volumes at a multispecialty cardiovascular center during the COVID-19 pandemic.

Neil M Kalwani, Esli Osmanlliu, Vijaya Parameswaran, Lubna Qureshi, Rajesh Dash, Paul A Heidenreich, David Scheinker, Fatima Rodriguez

Open access · bronzeAbstract read
In one paragraph

Article in Journal of telemedicine and telecare, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The digital journey: 25 years of digital development in electrophysiology from an Europace perspective.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Neil M KalwaniDivision of Cardiovascular Medicine and the Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-0075-6206
Esli OsmanlliuResearch Institute of the McGill University Health Centre, McGill University, Montréal, Canada.ORCID 0000-0001-5590-8866
Vijaya ParameswaranDivision of Cardiovascular Medicine and the Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Lubna QureshiDigital Health Care Integration, Stanford Health Care, Stanford, CA, USA.
Rajesh DashDivision of Cardiovascular Medicine and the Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Paul A HeidenreichDivision of Cardiovascular Medicine and the Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
David ScheinkerDepartment of Management Science and Engineering, Stanford University, Stanford, CA, USA.
Fatima RodriguezDivision of Cardiovascular Medicine and the Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-5226-0723
Cardiovascular Institute of the South · USMcGill University Health Centre · CAStanford Health Care · USStanford University · USVA Palo Alto Health Care System · US

Funding

Stanford Health Services Research Training ProgramT32HS026128 · AHRQ · STANFORD UNIVERSITY · PI BAKER, LAURENCE C, OWENS, DOUGLAS K · 2018 to 2024
$3.6M
SURPASS: (Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in minority Subgroups)K01HL144607 · NHLBI · STANFORD UNIVERSITY · PI RODRIGUEZ, FATIMA · 2019 to 2023
$856k
AHRQ HHS T32 HS026128NHLBI NIH HHS K01 HL144607
6 · The paper itself

Abstract

Early in the COVID-19 pandemic, cardiology clinics rapidly implemented telemedicine to maintain access to care. Little is known about subsequent trends in telemedicine use and visit volumes across cardiology subspecialties. We conducted a retrospective cohort study including all patients with ambulatory visits at a multispecialty cardiovascular center in Northern California from March 2019 to February 2020 (pre-COVID) and March 2020 to February 2021 (COVID). Telemedicine use increased from 3.5% of visits (1200/33,976) during the pre-COVID period to 63.0% (21,251/33,706) during the COVID period. Visit volumes were below pre-COVID levels from March to May 2020 but exceeded pre-COVID levels after June 2020, including when local COVID-19 cases peaked. Telemedicine use was above 75% of visits in all cardiology subspecialties in April 2020 and stabilized at rates ranging from over 95% in electrophysiology to under 25% in heart transplant and vascular medicine. From June 2020 to February 2021, subspecialties delivering a greater percentage of visits through telemedicine experienced larger increases in new patient visits (r = 0.81,

Indexed as

CardiologyCOVID-19TelemedicineHumansPandemicsRetrospective Studiescardiovascular diseaseCOVID-19Telecardiologytelehealthtelemedicine

Identifiers

PMID35108126
PMCPMC8814611
OpenAlexW4210570010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.